Literature DB >> 29590437

Insulin Resistance and β-Cell Dysfunction in Relation to Cardiometabolic Risk Patterns.

Tiange Wang1, Zhiyun Zhao1, Yu Xu1, Lu Qi2, Min Xu1, Jieli Lu1, Mian Li1, Yuhong Chen1, Meng Dai1, Wenhua Zhao3, Guang Ning1, Weiqing Wang1, Yufang Bi1.   

Abstract

Context: Insulin resistance (IR) and β-cell dysfunction are two major defects synergistically inducing the development of diabetes and related cardiometabolic disorders. Objective: To investigate the independent and joint associations of IR and β-cell dysfunction with the prevalence of multiple cardiometabolic disorders, including obesity, central obesity, diabetes, dyslipidemia, and hypertension. Design and Settings: A nationally representative population of 93,690 Chinese adults. Main Outcome Measures: IR and β-cell dysfunction were assessed by the homeostasis model assessment of IR (HOMA-IR) and of β-cell function (HOMA-B), respectively.
Results: High HOMA-IR was independently associated with high prevalence of all estimated cardiometabolic disorders, whereas low HOMA-B was independently associated with high prevalence of diabetes, dyslipidemia, and hypertension but low prevalence of obesity and central obesity. When examined jointly, the associations of HOMA-IR and HOMA-B with multiple cardiometabolic disorders showed different patterns with varying magnitudes. The strongest joint associations were observed for diabetes, with low HOMA-B associated with high prevalence of diabetes regardless of HOMA-IR; joint associations with dyslipidemia and hypertension prevalence appeared to be additive and had moderate changing trends; and low HOMA-B was not associated with high prevalence of obesity or central obesity unless combined with high HOMA-IR.
Conclusion: IR was associated with more prevalent cardiometabolic disorders than was β-cell dysfunction, and combinations of IR and β-cell dysfunction showed distinct relations with cardiometabolic risk patterns in Chinese adults.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29590437     DOI: 10.1210/jc.2017-02584

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Relationship between Decreased Serum Superoxide Dismutase Activity and Metabolic Syndrome: Synergistic Mediating Role of Insulin Resistance and β-Cell Dysfunction.

Authors:  Yiwen Liu; Chifa Ma; Lu Lv; Pingping Li; Chunxiao Ma; Shuli He; Jingbo Zeng; Fan Ping; Huabing Zhang; Wei Li; Lingling Xu; Yuxiu Li
Journal:  Oxid Med Cell Longev       Date:  2020-06-12       Impact factor: 6.543

2.  Impact of Baseline and Trajectory of Triglyceride-Glucose Index on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus.

Authors:  Shi Tai; Liyao Fu; Ningjie Zhang; Ying Zhou; Zhenhua Xing; Yongjun Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-24       Impact factor: 5.555

3.  Cardiometabolic risk factors in young Indian men and their association with parameters of insulin resistance and beta-cell function.

Authors:  Yashdeep Gupta; Alpesh Goyal; Mani Kalaivani; Nikhil Tandon
Journal:  World J Cardiol       Date:  2022-08-26

4.  Impact of triglycerides and waist circumference on insulin resistance and β-cell function in non-diabetic first-degree relatives of type 2 diabetes.

Authors:  Fahd Ahmed; Molham Al-Habori; Ebtesam Al-Zabedi; Riyadh Saif-Ali
Journal:  BMC Endocr Disord       Date:  2021-06-16       Impact factor: 2.763

5.  Triglyceride-glucose index in the development of peripheral artery disease: findings from the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Jing-Wei Gao; Qing-Yun Hao; Ming Gao; Kun Zhang; Xiong-Zhi Li; Jing-Feng Wang; Dominique A Vuitton; Shao-Ling Zhang; Pin-Ming Liu
Journal:  Cardiovasc Diabetol       Date:  2021-06-24       Impact factor: 9.951

6.  Association between mid-upper arm circumference and cardiometabolic risk in Chinese population: a cross-sectional study.

Authors:  Yanan Hou; Xu Jia; Liping Xuan; Wen Zhu; Chanjuan Deng; Long Wang; Zhiyun Zhao; Mian Li; Jieli Lu; Yu Xu; Yuhong Chen; Weiqing Wang; Yufang Bi; Min Xu; Tiange Wang
Journal:  BMJ Open       Date:  2019-09-08       Impact factor: 2.692

7.  Elevated Serum Level of Cytokeratin 18 M65ED Is an Independent Indicator of Cardiometabolic Disorders.

Authors:  Lingling Qian; Lei Zhang; Liang Wu; Jing Zhang; Qichen Fang; Xuhong Hou; Qiongmei Gao; Huating Li; Weiping Jia
Journal:  J Diabetes Res       Date:  2020-03-31       Impact factor: 4.011

8.  Hepatic steatosis is associated with abnormal hepatic enzymes, visceral adiposity, altered myocardial glucose uptake measured by 18F-FDG PET/CT.

Authors:  Lijun Hu; Xiaoliang Shao; Chun Qiu; Xiaonan Shao; Xiaosong Wang; Rong Niu; Yuetao Wang
Journal:  BMC Endocr Disord       Date:  2020-05-27       Impact factor: 2.763

9.  Administration of small-molecule guanabenz acetate attenuates fatty liver and hyperglycemia associated with obesity.

Authors:  Satoshi Yoshino; Yusaku Iwasaki; Shunichi Matsumoto; Tetsurou Satoh; Atsushi Ozawa; Eijiro Yamada; Satoru Kakizaki; Juan Alejandro Oliva Trejo; Yasuo Uchiyama; Masanobu Yamada; Masatomo Mori
Journal:  Sci Rep       Date:  2020-08-13       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.